SAN DIEGO (AP) _ Conatus Pharmaceuticals Inc. (CNAT) on Tuesday reported a loss of $3.3 million in its third quarter.
The San Diego-based company said it had a loss of 10 cents per share.
The biotechnology company posted revenue of $3.4 million in the period.
In the final minutes of trading on Tuesday, the company's shares hit 35 cents. A year ago, they were trading at $5.23.